另一方面,MNC 加速创新产品在中国落地,全年获批 53 款首次获批新药,较 2023 年上涨 29%,推动现有产品放量。其中武田获批新品最多,达 4 款,礼来、BMS 均获批 3 款,辉瑞、默沙东、罗氏、诺华也都有重磅产品获批。 参考来源: [1]公司官网/网络新闻 [2]https://www.biospace.com/business/10-best-selling-dr...
小编列出了药理学与药剂学(PHARMACOLOGY & PHARMACY)领域Top1-150的期刊信息供大家参考。 如您没有对我们公众号设为星标,也很少点在看,权重会降的非常低,有可能看不到我们的推文内容了。 将“大品种联盟”公众号设为星标⭐ 看完文章,在文末右下角给我们点...
另一方面,MNC 加速创新产品在中国落地,全年获批 53 款首次获批新药,较 2023 年上涨 29%,推动现有产品放量。其中武田获批新品最多,达 4 款,礼来、BMS 均获批 3 款,辉瑞、默沙东、罗氏、诺华也都有重磅产品获批。 参考来源: [1]公司官网/网络新闻 [2]https://www.biospace.com/business/10-best-selling-dr...
Projection of top global pharmaceutical products by revenue growth 2023 Merck & Co SG&A expenses 2014-2024 Share of global immunoglobulin therapies market 2017, by country Leading specialty therapy areas in the U.S. - unit cost change 2020 Italy: number of biotech orphan drugs drugs marketed 2016...
Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Each card includes: • Generic and common name • Dosage Forms • Approved Dose ...
The company's commitment to innovation is evident in its record-high R&D spending in 2023. This focus on research and development is crucial for maintaining competitiveness in the industry, as demonstrated by the changing rankings of top-selling drugs. For instance, AbbVie's Humira, once a ...
The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. ...
Top companies and drugs by sales in 2023doi:10.1038/d41573-024-00041-3Paul VerdinNature Reviews Drug Discovery
However, with reduced attention on COVID-19, sales of Comirnaty have sharply declined. In 2023, Pfizer announced a 500% price increase for the Comirnaty; however, the price hike has proven insufficient to address the downturn in product sales. On October 13th, Pfizer announced plans to cut...
The Fierce Pharma team compiled this report based on company filings and external resources such as the Corporate Pharmacy Serviceslist of upcoming generic drugsand asimilar listfrom Healthgrades. We only included drugs with a reasonable likelihood of using U.S. exclusivity in 2023, and we ranked ...